NFE2L2 and pancreatic ductal adenocarcinoma: Recently, it has been shown that TIGAR expression is dynamically regulated during the development of pancreatic ductal adenocarcinoma, and that together with NRF2 it has a key role in balancing ROS levels during the carcinogenic process [28].